10-Q

Company

Elicio Therapeutics, Inc.

Filed

May 13, 2025

Period of Report

March 31, 2025

Accession Number

0001601485-25-000074

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →